Very early researchStudy completedNCT01132014What this trial is testingAutologous OC-DC Vaccine in Ovarian CancerWho this might be right forChemotherapyTumorOvarian Cancer Abramson Cancer Center at Penn Medicine 67
Early research (Phase 1)UnknownNCT01387399What this trial is testingSafety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian CancerWho this might be right forOvarian Cancer University Hospital, Bonn 9
Early research (Phase 1)Study completedNCT02118285What this trial is testingIntraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal CancerWho this might be right forOvarian CancerFallopian Tube CarcinomaPrimary Peritoneal Carcinoma Masonic Cancer Center, University of Minnesota 2
Testing effectiveness (Phase 2)Study completedNCT00005952What this trial is testingTemozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorHead and Neck Cancer+5 more Duke University 30
Testing effectiveness (Phase 2)Ended earlyNCT04019288What this trial is testingAVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+6 more M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT07480954What this trial is testingDual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)Who this might be right forEpithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Carcinoma+1 more Beijing Biotech 36
Testing effectiveness (Phase 2)UnknownNCT05311579What this trial is testingNiraparib Plus Anlotinib for Recurrent Ovarian CancerWho this might be right forOvarian CarcinomaSurvival OutcomesAdverse Events+6 more Lei Li 36
Early research (Phase 1)Looking for participantsNCT06465069What this trial is testingLY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsWho this might be right forMetastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more Eli Lilly and Company 420
Testing effectiveness (Phase 2)Ended earlyNCT00006262What this trial is testingRebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial CancerWho this might be right forOvarian Cancer Northwestern University
Testing effectiveness (Phase 2)UnknownNCT05051696What this trial is testingIntra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological MalignanciesWho this might be right forGenital Neoplasms, Female Liu Zi 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04938583What this trial is testingOregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian CancerWho this might be right forOvarian Cancer by FIGO StageOvarian Cancer Stage IIIOvarian Cancer Stage IV CanariaBio Inc. 54
Early research (Phase 1)UnknownNCT03542669What this trial is testingStudy of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian CancerWho this might be right forRecurrent Ovarian CarcinomaPlatinum-resistant Ovarian Cancer Peking University People's Hospital 9
Early research (Phase 1)Looking for participantsNCT07030907What this trial is testingEvaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian CancerWho this might be right forOvarian Cancer RecurrentOvarian CancerPlatinum Resistant Ovarian Cancer Outpace Bio, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT00003852What this trial is testingCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell TumorsWho this might be right forChildhood Germ Cell TumorExtragonadal Germ Cell TumorOvarian Cancer+1 more UNICANCER 45
Testing effectiveness (Phase 2)UnknownNCT00036712What this trial is testingLight-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+9 more Medical College of Wisconsin 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07776171What this trial is testingTrastuzumab Rezetecan and Carboplatin ± Bevacizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-sensitive Recurrent Ovarian CancerWho this might be right forOvarian CancerPlatinum Sensitive Ovarian Cancer (PSOC) Sun Yat-sen University 176
Very early researchStudy completedNCT01626014What this trial is testingInteractive Educational Website for Women With Ovarian Cancer & CaregiversWho this might be right forStage III Ovarian CancerStage IV Ovarian CancerRecurrent Ovarian Cancer+1 more University of Minnesota 53
Testing effectiveness (Phase 2)Study completedNCT01238770What this trial is testingPhase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian CancerWho this might be right forEpithelial Ovarian Cancer Priv.-Doz. Dr. med. Joachim Rom 10
Testing effectiveness (Phase 2)Ended earlyNCT02055690What this trial is testingPAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian CancerWho this might be right forOvarian NeoplasmsNeoplasms, OvarianOvarian Cancer The Christie NHS Foundation Trust 21
Testing effectiveness (Phase 2)Ended earlyNCT02107378What this trial is testingEfficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian CarcinomaWho this might be right forEpithelial Ovarian Carcinoma SOTIO a.s. 22